A clinical trial depot is a regional warehouse holding investigational medicinal product and comparator drug for a running trial, positioned between the packaging site that prepares the trial supply and the individual sites where patients are dosed. Physically it looks like any other pharmaceutical cold store, refrigerated and frozen rooms plus ambient racking, but everything held inside belongs to a specific trial protocol and is tracked against a specific site's allocation rather than sold as general stock. A single depot commonly serves every site within one country or region, holding enough buffer that a site running low can be resupplied in days rather than waiting on a fresh shipment from the original packaging site overseas.
Sponsors and contract research organisations build a depot network, not one central depot, because a trial usually runs across many countries at once, and shipping every dose from a single origin to every site directly would mean customs clearance and import paperwork repeated for every shipment. Regional depots absorb that friction once per country instead of once per site delivery. A very small trial running in one or two countries, with a handful of sites and no multi-region distribution problem to solve, often ships directly from a single packaging site or one central depot and never needs a distributed network at all; the model earns its complexity at multi-region scale, not by default.
Import licences and country entry
Getting investigational product into a country legally requires an import licence or equivalent authorisation specific to that trial, obtained before the depot in that country can receive stock, separate from any authorisation the finished product might eventually hold if it is approved later. A depot cannot simply take delivery the way a commercial wholesaler receives standard stock; every incoming shipment has to match an approved import record for that specific protocol and that specific country. This is one of the more common causes of trial startup delay in a new country: the depot itself might be ready and qualified, but stock cannot move until the import licence clears, and that clock runs independently of anything happening at the sites themselves.
Holding several temperature bands at once
One depot commonly holds product across several bands in the same building: a room at 2-8°C for a biologic investigational product, a frozen room for a comparator that needs it, and ambient shelving for oral doses and ancillary trial supplies, all under one roof and one quality system. Each band runs its own qualification and monitoring, and a depot serving several trials at once is running that multiplied across every protocol it holds, each with its own storage condition and release criteria. Segregation between trials matters as much as segregation between temperature bands, since a depot mixing stock from two protocols on the same shelf risks a site receiving the wrong trial's product entirely.
Resupplying sites on demand
A depot's core job is turning an unpredictable site-level demand signal into a fast, small shipment rather than making every site hold its own large buffer. Interactive response technology tracks site inventory against a threshold and triggers a resupply order automatically once a site's stock runs low, and the depot ships against that trigger rather than a fixed schedule. That responsiveness is what keeps the total buffer held across the whole network smaller than it would need to be if every site tried to cover its own worst-case enrollment surge alone, since the depot absorbs that variability on behalf of many sites at once instead of each site absorbing it individually.
Returns and destruction
Every dose that leaves a depot has to be reconciled against what eventually comes back: dispensed to a patient, returned unused, or expired on the shelf. Sites typically return unused and expired product to the depot rather than destroying it locally, so the depot's own records, not a site's, become the definitive account of what happened to every unit issued under that protocol. Destruction itself usually happens through a certified vendor once a sponsor formally authorises it, with a certificate of destruction closing out the accountability record for those units. A depot cannot close out a trial's inventory record, and a sponsor cannot make an accurate accountability claim, until every unit is reconciled to dispensed, returned, or destroyed with nothing left unexplained.
Position in the wider supply chain
A depot is one link in the broader clinical trial supply logistics chain, sitting between the packaging site and the site pharmacy, and it exists mainly to shorten that last leg. Shipments in and out of a depot commonly travel in qualified insulated shippers sized for a short regional hop rather than the long-haul box built for the original international shipment into the country. Depot operators, sponsor supply chain teams, and site pharmacists all depend on the same depot inventory record, which is why a depot's system has to talk cleanly to both the sponsor's central tracking and the site's own drug accountability log, not sit as an island between them.